Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 13/20 | 0.49 |
| ▸ | PPARA | Q07869 | 11/20 | 0.49 |
| ▸ | CETP | P11597 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4511038 | 0.94 | PPARD (0.42) | PPARDPPARACETPPOLBHTR1A | |
| SCHEMBL4502832 | 0.89 | PPARD (0.53) | PPARDPPARAPPARG | |
| SCHEMBL4509002 | 0.89 | PPARD (0.58) | PPARDPPARAPPARG | |
| SCHEMBL4498481 | 0.88 | POLB (0.44) | PPARDPPARACETPPOLBPPARG | |
| SCHEMBL4801990 | 0.87 | PPARD (0.56) | PPARDPPARAHTR1APPARGMAPT | |
| SCHEMBL4801366 | 0.87 | PPARD (0.56) | PPARDPPARAHTR1APPARGMAPT | |
| SCHEMBL4803214 | 0.87 | PPARD (0.56) | PPARDPPARAHTR1APPARGMAPT | |
| SCHEMBL4508937 | 0.86 | PPARA (0.55) | PPARDPPARAPPARG | |
| SCHEMBL4522466 | 0.86 | PPARD (0.44) | PPARDPPARACETPPOLBPPARG | |
| SCHEMBL4503622 | 0.86 | PPARD (0.49) | PPARDPPARACETPPOLBPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203908-A1 | Activator for Peroxisome Proliferator-Activated Receptor | NIPPON CHEMIPHAR CO., LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| EP-1897872-A1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | Nippon Chemiphar Co., Ltd. (JP) | 2008-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203908-A1 | Activator for Peroxisome Proliferator-Activated Receptor | PPARA, PPARG, PPARD | PPARD 3/4885PPARA 1/4885CETP 1172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.